Spots Global Cancer Trial Database for Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome
Official Title: Minimal Stimulation or Clomiphene Citrate as First Line Therapy in Women With Polycystic Ovary Syndrome
Study ID: NCT01157312
Conditions
Study Description
Brief Summary: The purpose of this study is to compare and determine the the efficacy of minimal stimulation and clomiphene citrate(CC) as the first-line treatment in infertile women with Polycystic Ovary Syndrome(PCOS).
Detailed Description: All patients received 100 mg CC (Clomid®; Global Napi Pharmaceuticals, Cairo, Egypt) for 5 days starting from day 3 of spontaneous or induced menstruation. In group A (minimal stimulation), 2 vials of highly purified uFSH , 150 IU (Fostimon; IBSA, Lugano, Switzerland, 75 IU/vial) were given IM on cycle day 9. A total of 3 cycles was offered to each group.
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Mansoura University Hospitals,OB/GYN department, Mansoura, Dakahlia Governorate, Egypt
Contact Details
Name: Hatem Abu Hashim, MD MRCOG
Affiliation: Mansoura University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Mohamed F Bazeed, MD
Affiliation: Mansoura University Hospital
Role: STUDY_DIRECTOR
Name: Ibrahim Abd Elaal, MD
Affiliation: Mansoura University Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
